Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

niaprazine

Known as: N-(3-(4-(4-fluorophenyl)-1-piperazinyl)- 1-methylpropyl)-3-pyridinecarboxamide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Objective: Information on course and treatment of paroxysmal sympathetic hyperactivity (PSH) during rehabilitation and in… Expand
  • table 2
Is this relevant?
2006
2006
PURPOSE This study proposes to complete declarative studies by describing the prescriptions of anxiolytics, hypnotics, and… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2002
Review
2002
Insomnia in children is a nonspecific impairing symptom that may be the result of normal developmental changes, psychosocial… Expand
Is this relevant?
1999
1999
Niaprazine is a histamine H1-receptor antagonist with marked sedative properties. It has been employed in subjects with behavior… Expand
Is this relevant?
1991
1991
A placebo-controlled double-blind clinical trial on the effect of niaprazine on children with some common sleep disorders was… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1988
1988
1. The pharmacological profile of niaprazine was investigated using in vitro ligand binding techniques. 2. Niaprazine exhibits a… Expand
Is this relevant?
1982
1982
Niaprazine (60 mg/kg i.p.) increased rat brain 5-hydroxyindole acetic acid (5-HIAA) concentrations 30 min after treatment, and… Expand
Is this relevant?
1979
1979
Niaprazine (30–240 mg/kg i.p.) lowered rat brain levels of noradrenaline and dopamine, but did not alter levels of 5… Expand
Is this relevant?